|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00000277142 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
060712s2006 dcua ob 100 0 eng d |
| 005 |
20240703135929.9 |
| 019 |
|
|
|a 70136658
|a 744966795
|a 814454065
|a 1055335713
|a 1064140570
|a 1081208404
|a 1156334048
|a 1228572565
|a 1249248215
|
| 020 |
|
|
|a 0309659108
|q (electronic bk.)
|
| 020 |
|
|
|a 9780309659109
|q (electronic bk.)
|
| 020 |
|
|
|z 0309101611
|q (pbk.)
|
| 020 |
|
|
|z 9780309101615
|q (pbk.)
|
| 029 |
1 |
|
|a AU@
|b 000044593509
|
| 029 |
1 |
|
|a AU@
|b 000051482133
|
| 029 |
1 |
|
|a AU@
|b 000062432300
|
| 029 |
1 |
|
|a AU@
|b 000069534873
|
| 029 |
1 |
|
|a DEBBG
|b BV043161574
|
| 029 |
1 |
|
|a DEBBG
|b BV044051939
|
| 029 |
1 |
|
|a DEBSZ
|b 422269867
|
| 029 |
1 |
|
|a GBVCP
|b 802135633
|
| 035 |
|
|
|a (OCoLC)70289130
|z (OCoLC)70136658
|z (OCoLC)744966795
|z (OCoLC)814454065
|z (OCoLC)1055335713
|z (OCoLC)1064140570
|z (OCoLC)1081208404
|z (OCoLC)1156334048
|z (OCoLC)1228572565
|z (OCoLC)1249248215
|
| 035 |
|
|
|a (OCoLC)ocm70289130
|
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d YDXCP
|d OCLCQ
|d GPM
|d IDEBK
|d COF
|d OCLCQ
|d TFW
|d OCLCQ
|d LCS
|d OCLCQ
|d ZCU
|d OCLCF
|d OCLCQ
|d MMU
|d BAKER
|d CEF
|d COO
|d OCLCQ
|d NLGGC
|d OCLCQ
|d EBLCP
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCA
|d TOA
|d OCLCO
|d AGLDB
|d OCLCQ
|d MERUC
|d HTC
|d OCLCQ
|d MERER
|d OCLCO
|d OCLCA
|d BUF
|d OCLCO
|d GILDS
|d OCLCO
|d VNS
|d VTS
|d ICG
|d VT2
|d OCLCQ
|d OCLCO
|d WYU
|d OCLCO
|d LVT
|d STF
|d DKC
|d OCLCQ
|d OCLCO
|d M8D
|d OCLCQ
|d UKAHL
|d OCLCQ
|d OCLCA
|d AAA
|d OCLCO
|d SGP
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 050 |
|
4 |
|a RC180.5.A58
|b E97 2006eb
|
| 060 |
|
4 |
|a WC 556
|b .E96 2006
|
| 072 |
|
7 |
|a HEA
|x 039140
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 056000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.83
|2 22
|
| 111 |
2 |
|
|a Workshop on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication
|d (2005 :
|c Washington, D.C.)
|
| 245 |
1 |
0 |
|a Exploring the role of antiviral drugs in the eradication of polio :
|b workshop report /
|c Committee on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication, Board on Life Sciences, Division on Earth and Life Studies, National Research Council of the National Academies.
|
| 246 |
3 |
0 |
|a Antiviral drugs in the eradication of polio
|
| 260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c ©2006.
|
| 300 |
|
|
|a 1 online resource (x, 72 pages) :
|b illustrations (some color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Front Matter -- Acknowledgments -- Contents -- Summary -- 1 An Overview of the Polio Eradication Challenge -- 2 Public Health Considerations -- 3 Potential Biological Targets of Polio Antiviral Drugs -- 4 Development of Antiviral Drugs for Poliovirus -- 5 Implementation and Recommendations -- References -- Appendixes -- Appendix A Statement of Task -- Appendix B Committee Biographical Sketches -- Appendix C Workshop Agenda and Participant List
|
| 588 |
0 |
|
|a Print version record.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Poliomyelitis.
|
| 650 |
|
0 |
|a Antiviral agents
|x Therapeutic use.
|
| 650 |
|
0 |
|a Poliomyelitis vaccine, Oral.
|
| 650 |
1 |
2 |
|a Poliomyelitis
|x prevention & control
|
| 650 |
|
2 |
|a Poliomyelitis
|
| 650 |
2 |
2 |
|a Antiviral Agents
|x therapeutic use
|
| 650 |
2 |
2 |
|a Poliovirus Vaccine, Oral
|
| 655 |
|
2 |
|a Congress
|
| 655 |
|
7 |
|a proceedings (reports)
|2 aat
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
| 710 |
2 |
|
|a National Research Council (U.S.).
|b Committee on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication.
|
| 776 |
1 |
|
|a Exploring the role of antiviral drugs in the eradication of polio
|w (OCoLC)756599145
|
| 852 |
|
|
|b E-Collections
|h ProQuest
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=3564092
|z Full text (MCPHS users only)
|t 0
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36616911
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36567711
|
| 938 |
|
|
|a Baker & Taylor
|b BKTY
|c 18.00
|d .00
|i 0309101611
|n 0006767907
|s active
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3564092
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 161099
|
| 938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 46558
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 2448848
|
| 947 |
|
|
|a FLO
|x pq-ebc-base
|
| 999 |
f |
f |
|s 2a22e5c5-0e3c-48a8-b39e-9f7644a01716
|i f86a7e7b-5b77-4b09-b8d5-4e854bedfb97
|t 0
|
| 952 |
f |
f |
|a Massachusetts College of Pharmacy and Health Sciences
|b Online
|c Online
|d E-Collections
|t 0
|e ProQuest
|h Other scheme
|
| 856 |
4 |
0 |
|t 0
|u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=3564092
|y Full text (MCPHS users only)
|
